Fig. 3.

FGL2 levels in plasma. Each individual patient or control is shown as a circle, and bold lines are the mean values. a Levels of FGL2 in the NC group (n = 30), UC group (n = 50), and CD group (n = 45). b Levels of FGL2 in the NC group (n = 30), active UC group (n = 35), and inactive UC group (n = 15). c FGL2 levels in the NC group (n = 30), active CD group (n = 30), and inactive CD group (n = 15). The clinical details of the subjects are listed in Table 2. d Two CD patients with active disease, in both of whom the ileum and colon were involved, were both undergoing anti-TNF-α and azathioprine therapy. The line graphs labeled a and b represent the FGL2 levels of a 20-year-old female patient and a 24-year-old male patient, respectively, during the period of treatment. Each time is shown as a circle. UC (A) active UC, UC (I) inactive UC, CD (A) active CD, CD (I) inactive CD. *Significance compared with NC (P < 0.001); ^§significance compared with patients with inactive disease (P < 0.001)